Quantcast
Home > Quotes > VRAY

ViewRay, Inc. Common Stock (VRAY) Quote & Summary Data

VRAY 
$8.99
*  
0.02
0.22%
Get VRAY Alerts
*Delayed - data as of Jul. 17, 2018 11:45 ET  -  Find a broker to begin trading VRAY now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    VRAY Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 8.99 / $ 9.01
Today's High / Low
$ 9.10 / $ 8.83
Share Volume
151,346
50 Day Avg. Daily Volume
791,305
Previous Close
$ 8.97
52 Week High / Low
$ 10.64 / $ 4.40
Market Cap
675,007,129
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
151,346
50 Day Avg. Daily Volume:
791,305

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.83

Trading Range

The current last sale of $8.99 is 104.32% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 9.10 $ 10.64
 Low: $ 8.83 $ 4.40

ETFs with VRAY as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
0.16% Principal Healthcare Innovators Index ETF (BTEC) +2.16 (6.32%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

We design, manufacture and market the ViewRay MRIdian®, the only clinical MRI-guided radiation therapy system on the market. The MRIdian combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients. MRI is a broadly used imaging tool that has the ability to clearly differentiate between types of soft tissue. In contrast, X-ray or computed tomography (CT), the most commonly used imaging technologies in radiation therapy today, are often unable to distinguish soft tissues such as the tumor and critical organs. MRIdian integrates MRI technology, radiation delivery and our proprietary software to locate, target and track soft-tissue tumors, while radiation is delivered. These capabilities allow MRIdian to deliver radiation to the tumor more accurately, while reducing the radiation amount delivered to nearby healthy tissue, as compared to other radiation therapy treatments currently available.  ... More ...  

Risk Grade

Where does VRAY fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 8.94
Open Date:
Jul. 17, 2018
Close Price:
$ 8.97
Close Date:
Jul. 16, 2018

Consensus Recommendation

Analyst Info